First Nanotechnology Drug Approved for Breast Cancer

The government has just approved the first ever chemotherapy drug that uses nanotechnology to fight metastatic breast cancer. It's called Abraxane. It replaces toxic chemical treatment, with tiny packages of the drug paclitaxel and the natural protein albumin.
Researchers say the cancer cells believe they're taking in nutrients to help them grow, when they're really taking in the cancer fighting drug. Annice O'Brien took part in the study, 'It made me once again feel like i'm going to beat this.'
Dr. William Gradishar, Northwestern University, 'Abraxane is a new effective chemotherarpy drug for the treatment of metastatic breast cancer that can be administered over a very short period of time, and is well tolerated by patients.'
The drug offfers new hope for more than 215,000 women diagnosed with maglignant breast cancer each year.